• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对接受长期透析治疗超过十年的患者进行骨组织形态计量学分析。

Bone histomorphometrical analysis in patients on long-term dialysis treatment for more than ten years.

作者信息

Ubara Y

机构信息

Nephrology Center, Toranomon Hospital, Tokyo, Japan.

出版信息

Osaka City Med J. 1998 Dec;44(2):133-53.

PMID:10097595
Abstract

In Japan there is a steady increase in patients who have been on dialysis therapy for more than 10 years. Bone lesions could emerge as a serious problem during this dialysis period. From 1986 to 1993, bone lesions were examined by histomorphometry of the bone tissues (40 biopsis, 17 autopsies) in fifty seven patients who have undergone a long-term hemodialysis treatment (37 males, 20 females) at Toranomon hospital. Mean age of the patients was 56 +/- 11 (SD) years (range; 22 to 74) and mean dialysis period, 14.5 +/- 11 (SD) years (range; 10 to 28). The results were compared with biochemical and endocrinological data. The subjects were classified into osteitis fibrosa group (33%), osteomalacia group (12%), mixed group (7%) and mild group (48%). Intact parathyroid hormone (PTH) and alkaline phosphatase (Al-P) value were significantly higher in osteitis fibrosa and mixed groups, all cases showing intact-PTH values greater than 500 pg/ml (normal value; 20-53), but not in osteomalcia and mild groups. The analysis of 32 cases with intact-PTH higher than 500 pg/ml showed osteitis fibrosa in 59.4% mixed in 12.5%, osteomalacia in 3.1% and mild in 25%. Aluminum was positive in 41% for osteitis fibrosa, 25% for mixed, 60% for osteomalacia and 52% for mild group. In summary, cases having undergone hemodialysis more than 10 years showed higher frequency of osteitis fibrosa when intact-PTH exceeded 500 pg/ml. Al-P values in such cases were high in association with the intact-PTH values. There was no significant correlation between aluminum deposition and respective bone tissue types.

摘要

在日本,接受透析治疗超过10年的患者数量在稳步增加。在这段透析期间,骨病变可能会成为一个严重问题。1986年至1993年,对在虎之门医院接受长期血液透析治疗的57名患者(37名男性,20名女性)的骨组织进行组织形态计量学检查(40例活检,17例尸检)以检测骨病变。患者的平均年龄为56±11(标准差)岁(范围:22至74岁),平均透析时间为14.5±11(标准差)年(范围:10至28年)。将结果与生化和内分泌数据进行比较。受试者被分为纤维性骨炎组(33%)、骨软化症组(12%)、混合组(7%)和轻度组(48%)。纤维性骨炎组和混合组的完整甲状旁腺激素(PTH)和碱性磷酸酶(Al-P)值显著更高,所有病例的完整PTH值均大于500 pg/ml(正常值:20 - 53),而骨软化症组和轻度组则不然。对32例完整PTH高于500 pg/ml的病例分析显示,纤维性骨炎占59.4%,混合性占12.5%,骨软化症占3.1%,轻度占25%。纤维性骨炎组铝阳性率为41%,混合组为25%,骨软化症组为60%,轻度组为52%。总之,透析超过10年的病例在完整PTH超过500 pg/ml时纤维性骨炎发生率更高。此类病例的Al-P值与完整PTH值相关且较高。铝沉积与各骨组织类型之间无显著相关性。

相似文献

1
Bone histomorphometrical analysis in patients on long-term dialysis treatment for more than ten years.对接受长期透析治疗超过十年的患者进行骨组织形态计量学分析。
Osaka City Med J. 1998 Dec;44(2):133-53.
2
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.1α(OH)D3 一α-羟基胆钙化醇——一种活性维生素 D 类似物。关于慢性透析的尿毒症患者继发性甲状旁腺功能亢进症预防和治疗的临床研究。
Dan Med Bull. 2008 Nov;55(4):186-210.
3
The clinical spectrum of renal osteodystrophy in 57 chronic hemodialysis patients: a correlation between biochemical parameters and bone pathology findings.57例慢性血液透析患者肾性骨营养不良的临床谱:生化参数与骨病理结果的相关性
Clin Nephrol. 1991 Feb;35(2):78-85.
4
Elevated bone aluminum and suppressed parathyroid hormone levels in hypercalcemic dialysis patients.高钙血症透析患者骨铝升高及甲状旁腺激素水平受抑制。
Am J Nephrol. 1989;9(3):190-7. doi: 10.1159/000167964.
5
Bone aluminum and histomorphometric features of renal osteodystrophy.肾性骨营养不良的骨铝及组织形态计量学特征
J Clin Endocrinol Metab. 1982 Mar;54(3):539-46. doi: 10.1210/jcem-54-3-539.
6
Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.维持性血液透析的终末期肾衰竭患者甲状旁腺激素与左心室功能及结构的密切关联。
Acta Med Austriaca. 2004 Aug;31(3):67-72.
7
[Hemodialysis with 2.5 mEq/L of calcium in relative hypoparathyroidism: long-term effects on bone mass].相对甲状旁腺功能减退症患者使用2.5毫当量/升钙进行血液透析:对骨量的长期影响
Nefrologia. 2000 May-Jun;20(3):254-61.
8
Effects of vitamin K2 in hemodialysis patients with low serum parathyroid hormone levels.维生素K2对血清甲状旁腺激素水平低的血液透析患者的影响。
Bone. 2004 Mar;34(3):579-83. doi: 10.1016/j.bone.2003.11.016.
9
Controlled trial of calcitriol in hemodialysis patients.血液透析患者使用骨化三醇的对照试验。
Clin Nephrol. 1986 Oct;26(4):185-91.
10
Parathyroid interventions for secondary hyperparathyroidism in hemodialyzed patients.血液透析患者继发性甲状旁腺功能亢进的甲状旁腺干预措施。
Ther Apher Dial. 2005 Aug;9 Suppl 1:S11-5. doi: 10.1111/j.1744-9987.2005.00301.x.

引用本文的文献

1
The role of mast cells in parathyroid bone disease.肥大细胞在甲状旁腺骨病中的作用。
J Bone Miner Res. 2010 Jul;25(7):1637-49. doi: 10.1002/jbmr.49.
2
Differential effects of intermittent and continuous administration of parathyroid hormone on bone histomorphometry and gene expression.甲状旁腺激素间歇性和持续性给药对骨组织形态计量学及基因表达的不同影响。
Endocrine. 2002 Feb;17(1):29-36. doi: 10.1385/ENDO:17:1:29.